Researchers have demonstrated that deep learning models can help neurologists interpret epileptic episodes during and between seizures from relatively few scalp electroencephalography (EEG) readings.

The advance represents the first cancer-care pathway offering an automatically combined analysis of morphological, molecular and histological data. 

The FDA has greenlit an AI algorithm that automatically measures dilation in the heart’s right ventricle on CT images.

A manufacturer of compact MRI machines that leverage AI to upgrade image quality has received FDA’s blessing to market its technology in the U.S.

The European Union has granted CE mark approval to a U.S.-based maker of AI software that aids radiologists in distinguishing between benign and malignant lesions on breast ultrasound images.

The FDA has granted 510(k) clearance to clinical decision support software that uses AI to detect small but potentially cancerous lesions in the lungs.

The FDA has blessed an AI-packing armband that checks for biometric patterns pointing to possible SARS-CoV-2 infection in individuals with no symptoms.

If verified in additional trials, the advance will facilitate care planning much earlier than the current average age of diagnosis, 4 years old.

An MIT spinoff based in Boston and Milan in Italy has earned CE certification for software that flags respiratory infection in wearers of the company’s smartwatch devices.

The FDA has cleared an AI tool that helps radiologists diagnose or rule out prostate cancer on MRI scans.